3
Announcements
Trials
Browse
Landscape
Phase
Phase 1
1
Status
Completed
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Conditions
Thrombocytopenia
8
Myelodysplastic Syndromes
4
Leukemia, Myeloid, Acute
4
Leukemia
4
Purpura, Thrombocytopenic, Idiopathic
2
Leukemia, Myelomonocytic, Chronic
2
Leukemia, Lymphocytic, Chronic, B-Cell
2
Jacobs syndrome
2
Sarcoma
1
Primary Myelofibrosis
1
Myeloproliferative Disorders
1
Multiple Myeloma
1
Lymphoma, Non-Hodgkin
1
Leukemia, Myeloid, Chronic-Phase
1
Leukemia, Myeloid, Accelerated Phase
1
Healthy Volunteers
1
Healthy Adults
1
Blast Crisis
1
Anemia, Refractory, with Excess of Blasts
1
Anemia
1
Interventions
Rosuvastatin Calcium
2
technetium 99m HYNIC-duramycin
1
eltrombopag
1
darolutamide
1
Gelatin
1
Cell Death
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Completed
×
Healthy Volunteers
×
eltrombopag
×
Clear all
NCT04542382
2025-03-30
BCRPmarker
University of California, San Francisco
Phase 1
Completed
11 enrolled